173 related articles for article (PubMed ID: 35985743)
1. Obesity-related glomerulopathy in the presence of APOL1 risk alleles.
Valdez Imbert R; Hti Lar Seng NS; Stokes MB; Jim B
BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35985743
[TBL] [Abstract][Full Text] [Related]
2. APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI).
Abid Q; Best Rocha A; Larsen CP; Schulert G; Marsh R; Yasin S; Patty-Resk C; Valentini RP; Adams M; Baracco R
Am J Kidney Dis; 2020 Feb; 75(2):287-290. PubMed ID: 31601430
[TBL] [Abstract][Full Text] [Related]
3. Collapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigation.
Besse W; Mansour S; Jatwani K; Nast CC; Brewster UC
BMC Nephrol; 2016 Sep; 17(1):125. PubMed ID: 27600725
[TBL] [Abstract][Full Text] [Related]
4. Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 Cases.
Chang JH; Husain SA; Santoriello D; Stokes MB; Miles CD; Foster KW; Li Y; Dale LA; Crew RJ; Cohen DJ; Kiryluk K; Gharavi AG; Mohan S
Am J Kidney Dis; 2019 Jan; 73(1):134-139. PubMed ID: 30054024
[TBL] [Abstract][Full Text] [Related]
5. Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.
Atta MG; Estrella MM; Skorecki KL; Kopp JB; Winkler CA; Wasser WG; Shemer R; Racusen LC; Kuperman M; Foy MC; Lucas GM; Fine DM
Clin J Am Soc Nephrol; 2016 Feb; 11(2):262-70. PubMed ID: 26668025
[TBL] [Abstract][Full Text] [Related]
6. High risk APOL1 genotypes and kidney disease among treatment naïve HIV patients at Kano, Nigeria.
Abdu A; Duarte R; Dickens C; Dix-Peek T; Bala SM; Ademola B; Naicker S
PLoS One; 2022; 17(10):e0275949. PubMed ID: 36227935
[TBL] [Abstract][Full Text] [Related]
7. Sequencing rare and common APOL1 coding variants to determine kidney disease risk.
Limou S; Nelson GW; Lecordier L; An P; O'hUigin CS; David VA; Binns-Roemer EA; Guiblet WM; Oleksyk TK; Pays E; Kopp JB; Winkler CA
Kidney Int; 2015 Oct; 88(4):754-63. PubMed ID: 25993319
[TBL] [Abstract][Full Text] [Related]
8. The Impact of APOL1 on Chronic Kidney Disease and Hypertension.
Robinson TW; Freedman BI
Adv Chronic Kidney Dis; 2019 Mar; 26(2):131-136. PubMed ID: 31023447
[TBL] [Abstract][Full Text] [Related]
9.
Zhang JY; Wang M; Tian L; Genovese G; Yan P; Wilson JG; Thadhani R; Mottl AK; Appel GB; Bick AG; Sampson MG; Alper SL; Friedman DJ; Pollak MR
Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3446-3451. PubMed ID: 29531077
[TBL] [Abstract][Full Text] [Related]
10. APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestries.
Gribouval O; Boyer O; Knebelmann B; Karras A; Dantal J; Fourrage C; Alibeu O; Hogan J; Dossier C; Tête MJ; Antignac C; Servais A
Nephrol Dial Transplant; 2019 Nov; 34(11):1885-1893. PubMed ID: 29992269
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy.
Larsen CP; Beggs ML; Saeed M; Walker PD
J Am Soc Nephrol; 2013 Apr; 24(5):722-5. PubMed ID: 23520206
[TBL] [Abstract][Full Text] [Related]
12.
Friedman DJ; Pollak MR
Annu Rev Physiol; 2020 Feb; 82():323-342. PubMed ID: 31710572
[TBL] [Abstract][Full Text] [Related]
13. The evolving story of apolipoprotein L1 nephropathy: the end of the beginning.
Daneshpajouhnejad P; Kopp JB; Winkler CA; Rosenberg AZ
Nat Rev Nephrol; 2022 May; 18(5):307-320. PubMed ID: 35217848
[TBL] [Abstract][Full Text] [Related]
14. APOL1 Nephropathy: From Genetics to Clinical Applications.
Friedman DJ; Pollak MR
Clin J Am Soc Nephrol; 2021 Feb; 16(2):294-303. PubMed ID: 32616495
[TBL] [Abstract][Full Text] [Related]
15. APOL1 kidney risk alleles: population genetics and disease associations.
Limou S; Nelson GW; Kopp JB; Winkler CA
Adv Chronic Kidney Dis; 2014 Sep; 21(5):426-33. PubMed ID: 25168832
[TBL] [Abstract][Full Text] [Related]
16. Transplantation With APOL1 Risk Variant Kidney May Be Associated With Lifetime Risk for Recurrence of Focal Segmental Glomerulosclerosis: A Case Report and Review of Literature.
Mirza A; Kowalewska J; McCune T
Transplant Proc; 2019 Nov; 51(9):3077-3079. PubMed ID: 31324484
[TBL] [Abstract][Full Text] [Related]
17. AKI and Collapsing Glomerulopathy Associated with COVID-19 and
Wu H; Larsen CP; Hernandez-Arroyo CF; Mohamed MMB; Caza T; Sharshir M; Chughtai A; Xie L; Gimenez JM; Sandow TA; Lusco MA; Yang H; Acheampong E; Rosales IA; Colvin RB; Fogo AB; Velez JCQ
J Am Soc Nephrol; 2020 Aug; 31(8):1688-1695. PubMed ID: 32561682
[TBL] [Abstract][Full Text] [Related]
18. Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
Santoriello D; Husain SA; De Serres SA; Bomback AS; Crew RJ; Vasilescu ER; Serban G; Campenot ES; Kiryluk K; Mohan S; Hawkins GA; Hicks PJ; Cohen DJ; Radhakrishnan J; Stokes MB; Markowitz GS; Freedman BI; D'Agati VD; Batal I
Kidney Int; 2018 Dec; 94(6):1189-1198. PubMed ID: 30287079
[TBL] [Abstract][Full Text] [Related]
19. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
Anyaegbu EI; Shaw AS; Hruska KA; Jain S
Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
[TBL] [Abstract][Full Text] [Related]
20. APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.
Kasembeli AN; Duarte R; Ramsay M; Mosiane P; Dickens C; Dix-Peek T; Limou S; Sezgin E; Nelson GW; Fogo AB; Goetsch S; Kopp JB; Winkler CA; Naicker S
J Am Soc Nephrol; 2015 Nov; 26(11):2882-90. PubMed ID: 25788523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]